-
1
-
-
85004281132
-
-
2,226,340 (Chem Abstr 1973 78 159581)
-
C. A. Demerson, L. G. Humber, T. A. Dobson, and I. L. Jirkovsky, Ger. Offen. 1973, 2,226,340 (Chem. Abstr., 1973, 78, 159581).
-
(1973)
Ger. Offen.
-
-
Demerson, C.A.1
Humber, L.G.2
Dobson, T.A.3
Jirkovsky, I.L.4
-
2
-
-
0020062098
-
-
G. Vetter, M. Placchi, and L. Joubert, J. Clin. Pharmacol. Ther. Toxicol., 1982, 20, 240.
-
(1982)
J. Clin. Pharmacol. Ther. Toxicol.
, vol.20
, pp. 240
-
-
Vetter, G.1
Placchi, M.2
Joubert, L.3
-
3
-
-
0038268466
-
-
U. S. Patent 1998, 5,776,967 (Chem. Abstr., 1998, 129, 122569)
-
A. F. Kreft, C. E. Caufield, A. A. Failli, T. J. Caggiano, A. A. Greenfield, and D. M. Kubrak, U. S. Patent 1998, 5,776,967 (Chem. Abstr., 1998, 129, 122569).
-
-
-
Kreft, A.F.1
Caufield, C.E.2
Failli, A.A.3
Caggiano, T.J.4
Greenfield, A.A.5
Kubrak, D.M.6
-
4
-
-
0037593300
-
-
U. S. Patent 1998, 5,824,699 (Chem. Abstr., 1998, 129, 122569)
-
A. F. Kreft, C. E. Caufield, A. A. Failli, T. J. Caggiano, A. A. Greenfield, and D. M. Kubrak, U. S. Patent 1998, 5,824,699 (Chem. Abstr., 1998, 129, 122569).
-
-
-
Kreft, A.F.1
Caufield, C.E.2
Failli, A.A.3
Caggiano, T.J.4
Greenfield, A.A.5
Kubrak, D.M.6
-
5
-
-
0037593299
-
-
WO 2001, 01/06990 (Chem. Abstr., 2001, 134, 110452)
-
D. A. Carson, H. B. Cottam, S. Adachi, and L. M. Leoni, WO 2001, 01/06990 (Chem. Abstr., 2001, 134, 110452).
-
-
-
Carson, D.A.1
Cottam, H.B.2
Adachi, S.3
Leoni, L.M.4
-
6
-
-
0035991236
-
-
A. T. Koki, N. K. Khan, B. M. Woerner, K. Seibert, J. L. Harmon, A. J. Dannenberg, R. A. Soslow, and J. L. Masferrer, Prosglandins, Leukotrienes and Essential Fatty Acids, 2002, 66, 13.
-
(2002)
Prosglandins, Leukotrienes and Essential Fatty Acids
, vol.66
, pp. 13
-
-
Koki, A.T.1
Khan, N.K.2
Woerner, B.M.3
Seibert, K.4
Harmon, J.L.5
Dannenberg, A.J.6
Soslow, R.A.7
Masferrer, J.L.8
-
7
-
-
0033166010
-
-
Compound (2) has been determined by a 2 D NMR spectrum and correlation studies, see: S-Y. Chou, C-L. Tseng, and S-F. Chen, Heterocycles, 1999, 51, 1527.
-
(1999)
Heterocycles
, vol.51
, pp. 1527
-
-
Chou, S.-Y.1
Tseng, C.-L.2
Chen, S.-F.3
-
8
-
-
37049135944
-
-
A related skeletal rearrangement of a benzazepine skeleton, in which a tertiary amine acts as the nucleophilic center has been reported, see: H. Irie, S. Tani and H. Yamane. J. Chem. Soc., Perkin Trans. 1, 1972, 2986.
-
(1972)
J. Chem. Soc., Perkin Trans. 1
, vol.2986
-
-
Irie, H.1
Tani, S.2
Yamane, H.3
-
9
-
-
0038607393
-
-
note
-
The corresponding α- and β-methylene protons of the alcohol (20) and the bromide (21) also reveal comparable chemical shifts (see EXPERIMENTAL). The corresponding ring expansion skeleton would not show comparable signals.
-
-
-
-
10
-
-
0001022902
-
-
Phenyl-substituted tryptophols are prepared by refluxing the corresponding phenylhydrazines and 2-ethoxytetrahydrofuran in 95% ethanol, this process, is a modification of one in the literature, wherein 2-ethoxytetrahydrofuran is employed as the substitute for the highly acid-sensitive 2,3-dihydrofuran, see: B. Mckittrick, A. Failli, R. J. Steffan, R. M. Soll, P. Hughes, J. Schmid, A. A. Asselin, C. C. Shaw, R. Noureldin, and G. Gavin, J. Heterocycl. Chem., 1990, 27, 2151.
-
(1990)
J. Heterocycl. Chem.
, vol.27
, pp. 2151
-
-
Mckittrick, B.1
Failli, A.2
Steffan, R.J.3
Soll, R.M.4
Hughes, P.5
Schmid, J.6
Asselin, A.A.7
Shaw, C.C.8
Noureldin, R.9
Gavin, G.10
|